SFR1 inhibitors are a class of chemical compounds that target the SFR1 protein, which is an acronym for "SWI5-dependent recombination repair 1". This protein is a part of the complex cellular machinery involved in the homologous recombination repair process. Homologous recombination is a critical mechanism that cells employ to accurately repair harmful breaks in DNA that can occur during replication or as a result of environmental stresses. The SFR1 protein plays a pivotal role in this process by interacting with other proteins to facilitate the correct pairing of DNA strands, thereby ensuring the fidelity of genetic information during the repair. Inhibitors of SFR1 function by interfering with the protein's ability to perform its role in the homologous recombination pathway. They bind to SFR1 or its partners, disrupting the protein-protein interactions or the proper assembly of the recombination machinery. This inhibition can affect the stabilization of the protein complex that is necessary for the strand invasion step of homologous recombination, a critical phase where a damaged DNA strand invades a complementary DNA duplex to initiate repair.
The development and study of SFR1 inhibitors have expanded the understanding of the molecular mechanics of DNA repair. By observing the consequences of SFR1 inhibition at a cellular level, researchers are able to glean insights into the myriad processes that underlie genetic stability. SFR1 is understood to have a non-enzymatic role in homologous recombination, acting more as a scaffolding component that enhances the efficiency and specificity of the repair process rather than catalyzing a reaction directly. The study of SFR1 inhibitors thus can provide a window into the dynamic interactions between proteins involved in homologous recombination and can illuminate the diverse strategies cells use to maintain genomic integrity. These inhibitors, through their specific interaction with SFR1, have become valuable tools in the molecular biology field, enabling scientists to dissect the complex choreography of protein-protein interactions that safeguard the cell's genetic blueprint. By blocking the function of SFR1, these inhibitors serve as a means to perturb homologous recombination and thereby allow for the detailed study of this essential biological process.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin binds to FKBP12 and the complex inhibits the mTOR pathway, which can reduce the activity of SFR1 by limiting cell growth and proliferation signals that SFR1 may be involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that prevents AKT activation, subsequently affecting the PI3K/AKT/mTOR pathway, indirectly leading to decreased SFR1 activity by impairing survival signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a MEK inhibitor, which blocks the MAPK/ERK pathway, potentially resulting in reduced SFR1 signaling due to the inhibition of downstream transcription factors involved in cell cycle regulation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is another MEK inhibitor that prevents the activation of MAPK/ERK pathway, likely decreasing SFR1 activity by reducing the transcription of genes necessary for its functional signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, which could diminish SFR1 activity by preventing the phosphorylation of transcription factors that may regulate genes associated with SFR1 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that may reduce SFR1 activity by impairing inflammatory response signaling pathways, which could otherwise enhance SFR1 signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a PI3K inhibitor similar to LY294002, and its activity may lead to reduced SFR1 function by preventing growth factor-mediated survival and proliferation signals. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 is an Src family kinase inhibitor which could potentially decrease SFR1 activity by inhibiting signaling pathways related to cellular differentiation and proliferation. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $85.00 $132.00 $287.00 $495.00 $3752.00 | 42 | |
Erlotinib is an EGFR tyrosine kinase inhibitor which could result in decreased SFR1 activity by blocking signal transduction pathways involved in cell growth and differentiation. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Imatinib inhibits BCR-ABL tyrosine kinase, which may lead to a reduction in SFR1 activity by affecting downstream signaling pathways involved in cell cycle progression and survival. | ||||||